Address
Email address
Phone number
Website
https://www.safetoact.comHome | SafeToAct Ltd.We are an Estonian medical device start-up dedicated to developing high fidelity kidney replicas. Our mission is to improve patient healthcare by allowing physicians to train in a safe and controlled environment.
Name
OÜ SafeToAct
Registry code
12612926
VAT number
EE101765147
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
12.02.2014 (10)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
72191 - Other research and experimental development on natural sciences and engineering
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Omanikukonto: MAARJA KRUUSMAA 04.01.1970 (54) | 39% - 975.00 EUR | - | Direct ownership | Founder |
| Omanikukonto: SIIM KRUUSMAA 05.05.1962 (62) | 39% - 975.00 EUR | - | - | Founder |
| Peeter Ross 21.12.1966 (57) | 35% - 887.00 EUR | Board member | Direct ownership | Founder |
| Omanikukonto: ASKO RISTOLAINEN 27.12.1985 (38) | 26% - 638.00 EUR | Board member | Direct ownership | Founder |
| Tallinna Tehnikaülikool 74000323 | - | - | - | Founder |
| 2019 26.08.2020 | 2020 30.06.2021 | 2021 05.07.2022 | 2022 30.06.2023 | |
|---|---|---|---|---|
| Total Revenue | 18 900 € | 8 550 € | 1 750 € | 1 583 € |
| Net profit (loss) for the period | 14 903 € | 4 193 € | 267 € | 280 € |
| Profit Margin | 79% | 49% | 15% | 18% |
| Current Assets | 26 633 € | 7 234 € | 7 375 € | 8 436 € |
| Fixed Assets | 3 589 € | 2 820 € | 2 051 € | 1 282 € |
| Total Assets | 30 222 € | 10 054 € | 9 426 € | 9 718 € |
| Current Liabilities | 25 256 € | 895 € | 0 € | 12 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 4 966 € | 9 159 € | 9 426 € | 9 706 € |
| Employees | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | - | - | - |
| 2023 Q4 | 700 € | - | - | - |
| 2023 Q3 | 908.06 € | 120.7 € | - | - |
| 2023 Q2 | - | - | - | - |
| 2023 Q1 | - | - | - | - |
| 2022 Q4 | - | - | - | - |
| 2022 Q3 | - | - | - | - |
| 2022 Q2 | - | - | - | - |
| 2022 Q1 | 1 950.09 € | 124.79 € | - | - |
| 2021 Q4 | - | - | - | - |
| 2021 Q3 | - | - | - | - |
| 2021 Q2 | 800 € | 87.14 € | - | - |
| 2021 Q1 | 950 € | 573.63 € | 595.44 € | 1 |
| 2020 Q4 | 9 343 € | - | - | 1 |
| 2020 Q3 | - | - | - | - |
| 2020 Q2 | - | - | - | - |
| 2020 Q1 | - | - | - | - |
